Sanger Seminar Series
We are hosting a series of monthly freely available and open virtual seminars, showcasing how our researchers are tackling some of the greatest challenges in human health and disease. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty will present the latest developments in their field.
How to access the Seminars
The virtual seminar series will take place monthly and is freely available and open to all who wish to attend: https://stream.venue-av.com/e/sanger_seminars/login
Password (case sensitive): Sanger2020
Upcoming Seminars
Previous Sanger Seminars
Catch up on our previous talks
15 July - Dr Sarah Teichmann
Human Cell Atlas: Mapping the body one cell at a time
The Human Cell Atlas is an ambitious global initiative aiming to create a comprehensive reference map of all human cells—the fundamental units of life—as a basis understanding human health and diagnosing, monitoring, and treating disease.
In this talk Dr Sarah Teichmann explains how the Human Cell Atlas is providing unprecedented understanding of human cells and tissue architecture in health and disease including reproductive biology, auto-immune disease and Covid-19 infection.
Q&A with Dr Sarah Teichmann
The Q&A session with Dr Sarah Teichmann, Head of the Cellular Genetics research programme, was hosted by the Sanger Institute’s:
- Dr Mathew Garnett, Group Leader (from the Cancer, Ageing and Somatic Mutation research programme)
- Dr Roser Vento-Tormo, Group Leader (from the Cellular Genetics research programme)
- Dr Julia Wilson, Associate Director (from the Director’s Office)
19 August - Dr Peter Campbell
Somatic mutations in normal tissues
Dr Peter Campbell, Head of Cancer, Ageing and Somatic Mutation programme at the Sanger Institute discussed somatic mutations, and how researchers are characterising the landscape of mutations in cells to provide insights into normal tissue development and maintenance, cancer evolution, diseases other than cancer, and ageing.
Q&A with Dr Peter Campbell
The Q&A session with Dr Peter Campbell, Head of Cancer, Ageing and Somatic Mutation programme, was hosted by the Sanger Institute’s:
- Dr Mathew Garnett, Group Leader (from the Cancer, Ageing and Somatic Mutation research programme)
- Dr Roser Vento-Tormo, Group Leader (from the Cellular Genetics research programme)
- Dr Julia Wilson, Associate Director (from the Director’s Office)
16 September - Dr Emma Davenport
Stratifying sepsis patients through transcriptomic profiling
Dr Emma Davenport, Group Leader in the Human Genetics Programme at the Sanger Institute discussed somatic mutations, and how her research team is using gene expression data to understand how individuals respond to sepsis, a life-threatening condition caused by the dysregulated host response to infection.
Q&A with Dr Emma Davenport
The Q&A session with Dr Emma Davenport, Group Leader in the Human Genetics Programme, was hosted by the Sanger Institute’s:
- Dr Mathew Garnett, Group Leader (from the Cancer, Ageing and Somatic Mutation research programme)
- Dr Roser Vento-Tormo, Group Leader (from the Cellular Genetics research programme)
- Dr Julia Wilson, Associate Director (from the Director’s Office)